- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Arizona Will Extend Medicaid Program
Various states are contemplating whether or not to extend Medicaid programs under the healthcare reform act. The Washington Street Journal reports that Arizona is the latest state to officially extend the Medicaid program for its residents:
Arizona legislators voted to extend the state’s Medicaid program to include all adults earning a little more than the poverty level Thursday, giving a hard-fought victory to GOP Gov. Jan Brewer who had spent months campaigning for the move.
Ms. Brewer had held rallies across the state since January to persuade Republican legislators to go along with her decision to adopt a key part of the federal health-care law, the growth of the Medicaid health program to include millions more low-income adults, after the Supreme Court decision a year ago effectively allowed states to choose whether to participate.
“I am grateful to the Arizona lawmakers who have acted with courage and conviction by completing the people’s business,” Ms. Brewer said in a statement after the expansion passed the state senate Thursday afternoon.
Read the full story here: http://on.wsj.com/14AJR6P
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More
